RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to Apoptosis
暂无分享,去创建一个
Merlin C. Thomas | Merlin C Thomas | M. Cooper | E. Brennan | K. Sourris | A. El-Osta | J. Forbes | P. Kantharidis | M. Ziemann | M. Coughlan | R. Pickering | B. Harcourt | Shinji Hagiwara | A. McClelland | S. Penfold | G. Higgins | Muthukumar Mohan | Bo Wang | Wu Tieqiao | M. Thomas | Brooke E. Harcourt | M. Cooper
[1] E. Brennan,et al. Study of microRNA in diabetic nephropathy: Isolation, quantification and biological function , 2015, Nephrology.
[2] M. Torres-Ramos,et al. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. , 2014, CNS & neurological disorders drug targets.
[3] O. P. Kalra,et al. Role of advanced glycation end products ( AGEs ) – induced receptor ( RAGE ) expression in diabetic vascular complications , 2014 .
[4] M. Remáková,et al. The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis. , 2014, Rheumatology.
[5] K. Sourris,et al. Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes , 2014, Diabetologia.
[6] F. Ashcroft,et al. Deletion of Nicotinamide Nucleotide Transhydrogenase: A New Quantitive Trait Locus Accounting for Glucose Intolerance in C57BL/6J Mice. Diabetes 2006;55:2153–2156 , 2014, Diabetes.
[7] A. Simm,et al. Role of advanced glycation end products in cellular signaling , 2014, Redox biology.
[8] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[9] S. Phipps,et al. RAGE and TLRs: relatives, friends or neighbours? , 2013, Molecular immunology.
[10] B. Zhivotovsky,et al. S100A4 interacts with p53 in the nucleus and promotes p53 degradation , 2013, Oncogene.
[11] Jianling Xie,et al. Cellular signalling of the receptor for advanced glycation end products (RAGE). , 2013, Cellular signalling.
[12] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[13] Merlin C. Thomas,et al. Alagebrium Reduces Glomerular Fibrogenesis and Inflammation Beyond Preventing RAGE Activation in Diabetic Apolipoprotein E Knockout Mice , 2012, Diabetes.
[14] A. Schmidt,et al. Signal transduction in receptor for advanced glycation end products (RAGE). SOLUTION STRUCTURE OF C-TERMINAL RAGE (ctRAGE) AND ITS BINDING TO mDia1. , 2012, Journal of Biological Chemistry.
[15] A. Schmidt,et al. Signal Transduction in Receptor for Advanced Glycation End Products (RAGE) , 2011, The Journal of Biological Chemistry.
[16] S. Mishra,et al. S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence , 2011, Cancer and Metastasis Reviews.
[17] Merlin C. Thomas,et al. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. , 2010, American journal of physiology. Renal physiology.
[18] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[19] S. Yamagishi,et al. Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression. , 2010, Pharmacological research.
[20] M. Cooper,et al. RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes. , 2009, Journal of the American Society of Nephrology : JASN.
[21] R. Ramasamy,et al. The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease , 2009, Expert Reviews in Molecular Medicine.
[22] Merlin C. Thomas,et al. Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes , 2008, Diabetes.
[23] N. Kaminski,et al. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. , 2008, The American journal of pathology.
[24] C. Doglioni,et al. Maturing Dendritic Cells Depend on RAGE for In Vivo Homing to Lymph Nodes1 , 2008, The Journal of Immunology.
[25] M. Cooper,et al. Inhibition of NADPH Oxidase Prevents Advanced Glycation End Product–Mediated Damage in Diabetic Nephropathy Through a Protein Kinase C-α–Dependent Pathway , 2008, Diabetes.
[26] K. Herold,et al. Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo. , 2007, Journal of immunology.
[27] K. Herold,et al. Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. , 2007, Current molecular medicine.
[28] M. Rastaldi,et al. Apoptosis in the kidneys of patients with type II diabetic nephropathy. , 2007, Kidney international.
[29] L. Audoly,et al. Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE , 2007, Nature Immunology.
[30] M. Cooper,et al. Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? , 2007, Endocrinology.
[31] Masayoshi Takeuchi,et al. RAGE Control of Diabetic Nephropathy in a Mouse Model , 2006, Diabetes.
[32] Y. Tomino,et al. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] T. Imaizumi,et al. Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension. , 2005, Microvascular research.
[34] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] D. Stern,et al. Understanding RAGE, the receptor for advanced glycation end products , 2005, Journal of Molecular Medicine.
[36] U. Andersson,et al. RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages , 2005, Scandinavian journal of immunology.
[37] T. Kern,et al. High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. , 2005, Kidney international.
[38] R. Bucala,et al. AGEs activate mesangial TGF-b –Smad signaling via an angiotensin II type I receptor interaction , 2010 .
[39] Merlin C. Thomas,et al. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. , 2004, Diabetes.
[40] E. Schleicher,et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. , 2004, The Journal of clinical investigation.
[41] E. Bottinger,et al. Utility of endogenous creatinine clearance as a measure of renal function in mice. , 2004, Kidney international.
[42] L. Truong,et al. Advanced glycation end products activate Smad signaling via TGF‐β‐dependent and ‐independent mechanisms: implications for diabetic renal and vascular disease , 2004 .
[43] L. Denner,et al. Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice. , 2004, Diabetes.
[44] L. Truong,et al. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[45] G. Jerums,et al. The breakdown of pre‐existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[46] V. D’Agati,et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. , 2003, The American journal of pathology.
[47] S. Takasawa,et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. , 2003, The Biochemical journal.
[48] S. Menini,et al. Glomerular Cell Replication and Cell Loss through Apoptosis in Experimental Diabetes mellitus , 2002, Nephron.
[49] S. Takasawa,et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. , 2001, The Journal of clinical investigation.
[50] Hyung-Ryong Kim,et al. Molecular mechanism of staurosporine-induced apoptosis in osteoblasts. , 2000, Pharmacological research.
[51] V. D’Agati,et al. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. , 2000, Journal of the American Society of Nephrology : JASN.
[52] B. Brüne,et al. Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7receptors. , 1998, American journal of physiology. Renal physiology.
[53] B. Brüne,et al. Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7 receptors. , 1998, The American journal of physiology.
[54] G. Becker,et al. Evolution of tubulointerstitial fibrosis in experimental renal infection and scarring. , 1998, Journal of the American Society of Nephrology : JASN.
[55] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[56] W. Cefalu,et al. Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. , 1994, Clinical chemistry.
[57] M. Grigorian,et al. Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family. , 1989, Genes & development.